Ovarian stimulation and borderline ovarian tumors: a case-control study
- PMID: 9848294
- DOI: 10.1016/s0015-0282(98)00337-9
Ovarian stimulation and borderline ovarian tumors: a case-control study
Abstract
Objective: To assess the risk of borderline ovarian cancer among infertile women treated with fertility drugs.
Design: Case-control study.
Setting: Nationwide data obtained from public registers and postal questionnaires.
Patient(s): All Danish women <60 years old with borderline ovarian cancer during the period 1989-1994 and randomly selected population controls. The analysis included 231 cases and 1,721 controls.
Intervention(s): None.
Main outcome measure(s): Influence of parity, infertility, and fertility drugs on the risk of borderline ovarian cancer after multivariate confounder control.
Result(s): The odds ratio (OR) for borderline ovarian cancer among infertile untreated nulliparous women compared with fertile nulliparous women was 1.9. The OR for borderline ovarian cancer among treated nulliparous women compared with untreated infertile nulliparous women was 1.5, and the OR among treated parous women compared with untreated infertile parous women was 1.5.
Conclusion(s): Among fertile women, the difference in the risk of borderline ovarian cancer between nulliparous women and parous women was not statistically significant. Nulliparous women who were infertile and who did not receive medical treatment had a twofold higher risk of borderline ovarian cancer than fertile nulliparous women. There was no statistically significant increase in the risk of borderline ovarian cancer among nulliparous women who were treated with fertility drugs compared with nulliparous untreated infertile women or among parous women who were treated with fertility drugs compared with parous untreated infertile women.
Similar articles
-
Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.Fertil Steril. 2013 Jun;99(7):2031-6. doi: 10.1016/j.fertnstert.2013.02.010. Epub 2013 Apr 1. Fertil Steril. 2013. PMID: 23552324 Free PMC article.
-
Infertility, fertility drugs, and invasive ovarian cancer: a case-control study.Fertil Steril. 1997 Jun;67(6):1005-12. doi: 10.1016/s0015-0282(97)81431-8. Fertil Steril. 1997. PMID: 9176436
-
Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.Hum Reprod. 2015 Jan;30(1):222-31. doi: 10.1093/humrep/deu297. Epub 2014 Nov 5. Hum Reprod. 2015. PMID: 25376453
-
Fertility drug use and risk of ovarian tumors: a debated clinical challenge.Gynecol Endocrinol. 2013 Jan;29(1):30-5. doi: 10.3109/09513590.2012.705382. Epub 2012 Sep 5. Gynecol Endocrinol. 2013. PMID: 22946709 Review.
-
Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis.Fertil Steril. 2021 Jul;116(1):198-207. doi: 10.1016/j.fertnstert.2021.01.044. Fertil Steril. 2021. PMID: 34148584
Cited by
-
Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.Fertil Steril. 2013 Jun;99(7):2031-6. doi: 10.1016/j.fertnstert.2013.02.010. Epub 2013 Apr 1. Fertil Steril. 2013. PMID: 23552324 Free PMC article.
-
Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?Arch Gynecol Obstet. 2024 Apr;309(4):1515-1523. doi: 10.1007/s00404-023-07103-8. Epub 2023 Sep 26. Arch Gynecol Obstet. 2024. PMID: 37750934 Free PMC article.
-
Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):953-962. doi: 10.1158/1055-9965.EPI-16-0809. Epub 2017 Jan 20. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28108444 Free PMC article.
-
Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis.J Ovarian Res. 2023 Jan 24;16(1):22. doi: 10.1186/s13048-022-01084-z. J Ovarian Res. 2023. PMID: 36694251 Free PMC article.
-
Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.Front Endocrinol (Lausanne). 2019 May 24;10:313. doi: 10.3389/fendo.2019.00313. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31191449 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical